![Ernest D. Bush](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ernest D.
Bush formerly worked at Hoffmann-La Roche, Inc., as Senior Research Director & Head-Non-Clinical Drug, Akashi Therapeutics Inc, as Chief Scientific Officer, and ProMIS Neurosciences, Inc., as Head-Pharmacology & Toxicology.
Dr. Bush received his doctorate degree from the University of Washington and undergraduate degree and graduate degree from the University of Oregon.
| Companies | Position | End |
|---|---|---|
Akashi Therapeutics Inc
 Akashi Therapeutics Inc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Chief Tech/Sci/R&D Officer | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Chief Tech/Sci/R&D Officer | - |
| PROMIS NEUROSCIENCES, INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akashi Therapeutics Inc
Akashi Therapeutics Inc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
